Upgrade to SI Premium - Free Trial

Strategy (MSTR) PT Raised to $464 at Canaccord Genuity

May 2, 2025 6:39 AM
Canaccord Genuity analyst Joe Vafi raised the price target on Strategy (NASDAQ: MSTR) to $464.00 (from $409.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles